Evidence map›Paper›PMID 41754971›Full record

ArticlePharmaceutics2026

Employing a Combination of Chemoattractants to Trap Glioblastoma Cells in a Macroporous Hydrogel.

Sahar Naasri, Hélène Therriault, Lisa Delattre, Nick Virgilio, Marc-Antoine Lauzon, Nathalie Faucheux, Benoit Paquette

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sahar NaasriCenter for Research in Radiotherapy, Department of Medical Imaging and Radiation Sciences, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.ORCID 0009-0007-6690-583X
Hélène TherriaultCenter for Research in Radiotherapy, Department of Medical Imaging and Radiation Sciences, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Lisa DelattreResearch Center for High Performance Polymer and Composite Systems (CREPEC), Department of Chemical Engineering, Polytechnique Montreal, Montreal, QC H3C 3A7, Canada.
Nick VirgilioResearch Center for High Performance Polymer and Composite Systems (CREPEC), Department of Chemical Engineering, Polytechnique Montreal, Montreal, QC H3C 3A7, Canada.
Marc-Antoine LauzonDepartment of Chemical and Biotechnological Engineering, Faculty of Engineering, Universite de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.ORCID 0009-0007-0576-7322
Nathalie FaucheuxDepartment of Chemical and Biotechnological Engineering, Faculty of Engineering, Universite de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.ORCID 0000-0003-0855-9186
Benoit PaquetteCenter for Research in Radiotherapy, Department of Medical Imaging and Radiation Sciences, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0002-2117-8372

Funding

Fonds de Recherche du Québec-Nature et Technologie 299713New Frontiers in the Research Fund NFRFE-2018-00764
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cytokineglioblastomamacroporous hydrogelmigration

Identifiers

PMID41754971
PMCPMC12944073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.